Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial
Gavin A. Lewis, Susanna Dodd, Dannii Clayton, Emma Bedson, Helen Eccleson, Erik B. Schelbert, Josephine H. Naish, Beatriz Duran Jimenez, Simon G. Williams, Colin Cunnington, Fozia Ahmed, Anne Cooper, Rajavarma Viswesvaraiah, Stuart D Russell, Theresa McDonagh, Paula Williamson, Chris Miller
Topics & Concepts
PirfenidoneMedicineEjection fractionInternal medicineHeart failurePlaceboHeart failure with preserved ejection fractionCardiologyIdiopathic pulmonary fibrosisAdverse effectRandomized controlled trialLungPathologyAlternative medicineInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisHeart Failure Treatment and ManagementCardiovascular Function and Risk Factors